Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Suven Pharmaceuticals reports 12% revenue growth for Q2 with strong outlook
Suven Pharmaceuticals Ltd. (BSE: 530239, NSE: SUVENPHARM), a technology-focused Contract Development and Manufacturing Organization (CDMO) headquartered in Hyderabad,…
Recce Pharmaceuticals to begin Phase 3 trials in Indonesia for diabetic foot infection treatment
Recce Pharmaceuticals Limited has received ethics approval from Indonesia’s Human Research Ethics Committee to initiate Phase 3 clinical…
AbbVie’s schizophrenia treatment crumbles, boosting Bristol Myers Squibb to the top
Bristol Myers Squibb’s stock surged dramatically after pharmaceutical giant AbbVie announced disappointing results in its recent clinical trials…
Avid Bioservices to exit public market with GHO and Ampersand buyout
In a transformative shift within the biopharmaceutical manufacturing sector, Avid Bioservices, a premier biologics contract development and manufacturing…
Granules India gains key FDA approval for Unit V facility, marking major compliance milestone
Hyderabad-based Granules India Limited has achieved a significant regulatory milestone, securing an Establishment Inspection Report (EIR) with a…
Breakthrough EU approval for Dupixent offers new hope for children with eosinophilic esophagitis
The European Medicines Agency (EMA) has granted approval for Dupixent, a therapy developed by Sanofi and Regeneron, to…
Canada approves GSK’s Arexvy vaccine for RSV protection in adults 50-59 at elevated risk
In a crucial development for public health, Health Canada has extended its approval for GlaxoSmithKline’s Arexvy vaccine to…
Breakthrough in mental health treatment: Intra-Cellular’s Caplyta emerges as a beacon of hope for schizophrenia patients
In a significant development for schizophrenia management, Intra-Cellular Therapies has announced impressive outcomes from a late-stage, Phase III…
Ichnos Glenmark Innovation’s phase 1 study of trispecific antibody shows strong results in myeloma treatment
Ichnos Glenmark Innovation (IGI), a collaboration between Glenmark Pharmaceuticals Limited and Ichnos Sciences Inc., has unveiled promising results…
Hims & Hers’ earnings soar while GLP-1 drug crisis deepens—what this means for investors
Hims & Hers Health Inc. saw its stock surge following a robust quarterly earnings report, which showcased significant…